I have been paying close attention to Kalaris Therapeutics ( KLRS ), and my bullish position regarding Kalaris is not simply related to the presence of another retinal therapeutic agent in the crowded pipeline. My bullish thesisI have a strong inclination towards high-growth companies, often treading in sectors poised for exponential expansion. My expertise lies in understanding and investing in disruptive technologies and forward-thinking enterprises. My approach is a mix of fundamental analysis and future ...